Cite
A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosis.
MLA
Kreitz, Kiana, et al. “A New Risk Score for Patients after First Recurrence of Stage 4 Neuroblastoma Aged ≥18 Months at First Diagnosis.” Cancer Medicine, vol. 8, no. 17, Dec. 2019, pp. 7236–43. EBSCOhost, https://doi.org/10.1002/cam4.2562.
APA
Kreitz, K., Ernst, A., Schmidt, R., Simon, T., Fischer, M., Volland, R., Hero, B., & Berthold, F. (2019). A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosis. Cancer Medicine, 8(17), 7236–7243. https://doi.org/10.1002/cam4.2562
Chicago
Kreitz, Kiana, Angela Ernst, René Schmidt, Thorsten Simon, Matthias Fischer, Ruth Volland, Barbara Hero, and Frank Berthold. 2019. “A New Risk Score for Patients after First Recurrence of Stage 4 Neuroblastoma Aged ≥18 Months at First Diagnosis.” Cancer Medicine 8 (17): 7236–43. doi:10.1002/cam4.2562.